CYTK logo

Cytokinetics Inc (CYTK)

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
CYTK
ISIN Code
US23282W6057
Currency
US Dollar (USD)
IPO Date
2004-04-29

Contact Information

Company Address
350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Contact Phone
650 624 3000
Company Website
https://www.cytokinetics.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$-999,999.99
Return on Assets (TTM)
-28.09%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99